TIMP3 checks inflammation
- 1 September 2004
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 36 (9) , 934-935
- https://doi.org/10.1038/ng0904-934
Abstract
Mice deficient in the metalloprotease inhibitor TIMP3, which inhibits the tumor-necrosis factor alpha (TNF-alpha)-converting enzyme (TACE, also called ADAM17), have elevated levels of TNF and severe inflammation in the liver. This result confirms the physiological importance of the soluble form of TNF and identifies TIMP3 as a crucial regulator of this inflammatory cytokine.Keywords
This publication has 13 references indexed in Scilit:
- Abnormal TNF activity in Timp3−/− mice leads to chronic hepatic inflammation and failure of liver regenerationNature Genetics, 2004
- TIMPs as multifacial proteinsCritical Reviews in Oncology/Hematology, 2004
- A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2Nature Medicine, 2003
- Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3Gene Therapy, 2003
- Metalloproteinase inhibitors: biological actions and therapeutic opportunitiesJournal of Cell Science, 2002
- Tumor necrosis factor-α converting enzymeThe International Journal of Biochemistry & Cell Biology, 2002
- Matrix MetalloproteinasesJournal of Biological Chemistry, 1999
- TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3FEBS Letters, 1998
- Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.Journal of Clinical Investigation, 1998
- Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-αNature, 1997